Clover Biopharmaceuticals, Ltd. (02197)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Leggett Thomas | 26-Sep-21 | INED | |||
| Ralf Leo Clemens | 19-Jun-25 | Non-Executive Director | Dr. Clemens did not stand for re-election at the Annual General Meeting due to his need to allocate more time to family and personal affairs. He has confirmed that he has no disagreement with the Board and there are no matters with respect to his retirement that need to be brought to the attention of the Stock Exchange or the Shareholders. | ||
| Krex Brian | 19-Apr-21 | 31-Mar-23 | CoSec | Due to his other work commitments | |
| Krex Brian | 31-Mar-23 | J-CoSec | Due to his other work commitments | ||
| Lyu Dong | 16-Mar-21 | 28-Oct-22 | Non-Executive Director | To focus on other business priorities | |
| Wang Xiaodong | 16-Mar-21 | 18-May-22 | Non-Executive Director | ||
| Xiao Ting | 16-Mar-21 | 22-Apr-22 | Non-Executive Director | To focus on other business priorities | |
| Fung Po Ting | 19-Apr-21 | 22-Dec-21 | CoSec | ||
| Liao Xiang | 26-Sep-21 | 29-Jan-14 | INED | ||
| Farrow Jeffrey | 26-Sep-21 | 04-May-11 | INED | ||
| Clemens Ralf Leo | 17-Jun-22 | 13-Aug-08 | Non-Executive Director | ||
| Wu Xiaobin | 26-Sep-21 | 01-Nov-05 | INED | ||
| Liang Peng | 31-Oct-18 | 16-Aug-00 | Fdr | ||
| Ambrosino Donna Marie | 17-Jun-22 | 31-Jan-00 | Non-Executive Director | ||
| Chau Anita Hing Ling | 22-Dec-21 | 12-Mar-97 | CoSec | ||
| Liang Joshua G | 25-Dec-20 | 12-Mar-97 | CEO | ||
| Liang Peng | 31-Oct-18 | 31-Aug-93 | Ch | ||
| Wang Xiaoyan | 31-Mar-23 | 31-Aug-93 | CoSec |